An observational study in Resectable Pancreatic Head Neoplasm, Resectable Periampullary Neoplasm and Chronic Pancreatitis, sponsored by Universitätsklinikum Hamburg-Eppendorf. Completed at 3 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-29.
Sponsored by Universitätsklinikum Hamburg-Eppendorf · Observational
Including 150 randomised patient, the studies aim is to determine whether an economisation and/or improvement in terms of operating time, drainage fluid, blood loss, time of hospitalisation can be found using an ultrasonic dissection device versus traditional surgical methods such as stitches an ligations.The study is performed for patients undergoing partial pancreatoduodenectomy.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's enrollment of 82 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Universitätsklinikum Hamburg-Eppendorf is the lead sponsor of 403 studies on the registry; 83 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients planned for partial pancreatoduodenectomy for pancreatic head carcinoma, periampullary carcinoma, chronic pancreatitis and other benign lesions.
resectable tumor
Exclusion Criteria:
palliative resection
Preparation with Harmonic WAVE
Preparation with conventional modalities
Total operation time
Measurement of time regarding incision-closure-time
Time frame: end of operation
intraoperative blood loss
Time frame: end of operation
number of transfusions
Time frame: within the first 24 hours perioperatively
hospitalization time
Time frame: end of hospitalization
resulting cost reduction
Time frame: end of hospitalization
pancreatic fistula
Time frame: within the first 5 days postoperatively
postoperative intervention
Postoperative interventions due complications, e.g. pancreatic fistula
Time frame: end of hospitalization
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsklinikum Hamburg-Eppendorf